Mid-Point Analysis of Pivotal Phase 3 SIERRA Trial Including Material Presented at 2020 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT) Feb 20, 2020
Iomab-B Single Agent Activity: 2019 SOHO Annual Meeting Honorable Distinction Award Recipient Sep 23, 2019
225Ac-CD38 Antibody Targeting is Effective and Well Tolerated in Experimental Models of Lymphoma and Multiple Myeloma Jun 25, 2019
